Tianda Pharmaceuticals Ltd 2021 SR
The report highlights Tianda Pharmaceuticals Limited's ESG performance for the fiscal year 2020-2021, focusing on its three strategic pillars: Traditional Chinese Medicine, innovative drugs, and healthcare services. The company identified 16 material ESG issues and implemented measures to reduce environmental impacts, such as installing wastewater treatment systems and using cleaner diesel. Key achievements include receiving the Greater Bay Area Sustainable Business Award for Health and Wellness and the Caring Company logo. The Group also actively contributed to COVID-19 relief efforts by developing anti-epidemic Chinese medicine formulas and providing free medical consultations in the community.
Company: Tianda Pharmaceuticals Ltd
Sector: Health Care
Country: Hong Kong
Year: 2021
Type: SR
Pages: 24
Tianda Pharmaceuticals Ltd
ESG Report
The report highlights Tianda Pharmaceuticals Limited's ESG performance for the fiscal year 2020-2021, focusing on its three strategic pillars: Traditional Chinese Medicine, innovative drugs, and healthcare services. The company identified 16 material ESG issues and implemented measures to reduce environmental impacts, such as installing wastewater treatment systems and using cleaner diesel. Key achievements include receiving the Greater Bay Area Sustainable Business Award for Health and Wellness and the Caring Company logo. The Group also actively contributed to COVID-19 relief efforts by developing anti-epidemic Chinese medicine formulas and providing free medical consultations in the community.
Sign in for free to access detailed sustainability data, reporting standards, and ESG metrics.
Document Details
Report Year
2021
Reporting Period
Apr 1, 2020 - Mar 31, 2021
Fiscal Year
2021
Published
Oct 22, 2021
Type
Sustainability Report
Language
English
Pages
File Size
Standards & Assurance
Materiality Assessment
Other Standards
ESG Data?Experimental — AI-extracted data, may contain inaccuracies
Emissions
Scope 1:
Water Consumption
Total Waste